Adaptive tcr seattle

Adaptive Tcr. Adaptive Tcr Corp. Adaptive Symbiotic Technologies Biological Labs. Website More Info. Website Directions More Info. Our products will help make disease history. See our Clinical Portfolio and Pipeline. Life Sciences Research. Sequence immune receptors accurately and at scale. Sequence and map immune receptors to disease-specific antigens. Clinical Diagnostics. Assess MRD for blood cancer patients. Detect disease-specific T-cell signatures.

Drug Discovery. Identify T-cell receptors for cancer cellular therapy. Identify neutralizing antibodies for therapeutic use. We are currently leveraging our TCR discovery capabilities to enable commercialization of novel therapies by collaborators.

In the future, we may explore expanding our end-to-end capabilities for the development of cellular therapies and vaccines. TruTCR is summarized in the figure below. Adaptive will use its immune medicine platform to screen, identify, and characterize TCRs against shared cancer antigens from blood of healthy donors. Genentech will use these patient-specific TCRs to engineer and manufacture a personalized cellular medicine and deliver it to each patient.

Adaptive aims to use its immune medicine platform outside of this collaboration for the development of cellular therapies in other disease areas, including autoimmune conditions and infectious diseases.